Activation of cathepsin D by glycosaminoglycans

FEBS Journal

Volumn 276, Issue 24, 2009, Pages 7343-7352

  Beckman, Marie ^a,b   Freeman, Craig ^c   Parish, Christopher R ^c   Small, David H ^d  

^a School of Life Sciences Södertörn University   (Sweden)

^b MONASH UNIVERSITY   (Australia)

^c Biology and Environment   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Aspartic protease; Cathepsin D; Glycosaminoglycan; Heparin; Proteolytic activity

Indexed keywords

AMINO ACID; CATHEPSIN D; ENZYME PRECURSOR; GLYCOSAMINOGLYCAN; HEPARIN; PROCATHEPSIN D; SULFATE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; SPLEEN; SULFATION;

CATHEPSIN D; ENZYME ACTIVATION; ENZYME PRECURSORS; GLYCOSAMINOGLYCANS; HEPARIN;

EID: 71949093178     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07444.x     Document Type: Article

References (43)

1. Benes P, Vetvicka V Fusek M (2008) Cathepsin D - many functions of one aspartic protease. Crit Rev Oncol Hematol 68, 12 28.
2. Liaudet-Coopman E, Beaujouin M, Derocq D, Garcia M, Glondu-Lassis M, Laurent-Matha V, Prebois C, Rochefort H Vignon F (2006) Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett 237, 167 179.
3. Zaidi N, Maurer A, Nieke S Kalbacher H (2008) Cathepsin D: a cellular roadmap. Biochem Biophys Res Commun 376, 5 9.
4. Erickson AH (1989) Biosynthesis of lysosomal endopeptidases. J Cell Biochem 40, 31 41.
5. Glondu M, Coopman P, Laurent-Matha V, Garcia M, Rochefort H Liaudet-Coopman E (2001) A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene 20, 6920 6929.
6. Ohri SS, Vashishta A, Proctor M, Fusek M Vetvicka V (2008) The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells. Int J Oncol 32, 491 498.
7. Kim S, Ock J, Kim AK, Lee HW, Cho JY, Kim DR, Park JY Suk K (2007) Neurotoxicity of microglial cathepsin D revealed by secretome analysis. J Neurochem 103, 2640 2650.
8. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, Lippa C Nixon RA (1995) Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14, 671 680.
9. Nixon RA, Mathews PM Cataldo AM (2001) The neuronal endosomal-lysosomal system in Alzheimer's disease. J Alzheimers Dis 3, 97 107.
10. Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB et al. (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2, 5.
11. Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, Xie ZL, Speake LD, Parks R, Crabtree D et al. (2008) Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol Brain 1, 17.
12. Sevlever D, Jiang P Yen SH (2008) Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 47, 9678 9687.
13. Beckman M, Holsinger RM Small DH (2006) Heparin activates beta-secretase (BACE1) of Alzheimer's disease and increases autocatalysis of the enzyme. Biochemistry 45, 6703 6714.
14. Vassar R (2002) Beta-secretase (BACE) as a drug target for Alzheimer's disease. Adv Drug Deliv Rev 54, 1589 1602.
15. Hileman RE, Fromm JR, Weiler JM Linhardt RJ (1998) Glycosaminoglycan- protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays 20, 156 167.
16. Gandhi NS Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72, 455 482.
17. Masa M, Maresova L, Vondrasek J, Horn M, Jezek J Mares M (2006) Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core. Biochemistry 45, 15474 15482.
18. Egeberg M, Kjeken R, Kolset SO, Berg T Prydz K (2001) Internalization and stepwise degradation of heparan sulfate proteoglycans in rat hepatocytes. Biochim Biophys Acta 1541, 135 149.
19. Yanagishita M Hascall VC (1992) Cell surface heparan sulfate proteoglycans. J Biol Chem 267, 9451 9454.
20. Hasilik A, von Figura K, Conzelmann E, Nehrkorn H Sandhoff K (1982) Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. Eur J Biochem 125, 317 321.
21. Wittlin S, Rosel J, Hofmann F Stover DR (1999) Mechanisms and kinetics of procathepsin D activation. Eur J Biochem 265, 384 393.
22. Nandini CD Sugahara K (2006) Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors. Adv Pharmacol 53, 253 279.
23. Conner GE Richo G (1992) Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. Biochemistry 31, 1142 1147.
24. Caglic D, Pungercar JR, Pejler G, Turk V Turk B (2007) Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions. J Biol Chem 282, 33076 33085.
25. Fairhead M, Kelly SM van der Walle CF (2008) A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activation. Biochem Biophys Res Commun 366, 862 867.
26. Sorensen HP, Vives RR, Manetopoulos C, Albrechtsen R, Lydolph MC, Jacobsen J, Couchman JR Wewer UM (2008) Heparan sulfate regulates ADAM12 through a molecular switch mechanism. J Biol Chem 283, 31920 31932.
27. Vasiljeva O, Dolinar M, Pungercar JR, Turk V Turk B (2005) Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans. FEBS Lett 579, 1285 1290.
28. Laurent-Matha V, Derocq D, Prebois C, Katunuma N Liaudet-Coopman E (2006) Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B. J Biochem 139, 363 371.
29. Piwnica D, Fernandez I, Binart N, Touraine P, Kelly PA Goffin V (2006) A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. Mol Endocrinol 20, 3263 3278.
30. Vreys V David G (2007) Mammalian heparanase: what is the message? J Cell Mol Med 11, 427 452.
31. Nagasawa K, Inoue Y Kamata T (1977) Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanol. Carbohydr Res 58, 47 55.
32. Jaseja M, Rej RN, Sauriol F Perlin AS (1989) Novel regio- and stereoselective modifications of heparin in alkaline solution. Nuclear magnetic resonance spectroscopic evidence. Can J Chem 67, 1449 1456.
33. Inoue Y Nagasawa K (1976) Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol. Carbohydr Res 46, 87 95.
34. Yates EA, Santini F, Guerrini M, Naggi A, Torri G Casu B (1996) 1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydr Res 294, 15 27.
35. Karamanos NK, Hjerpe A, Tsegenidis T, Engfeldt B Antonopoulos CA (1988) Determination of iduronic acid and glucuronic acid in glycosaminoglycans after stoichiometric reduction and depolymerization using high-performance liquid chromatography and ultraviolet detection. Anal Biochem 172, 410 419.
36. Toida T, Suzuki A, Nakajima K, Chaidedgumjorn A Imanari T (2000) Effect of 6-O-sulfonate hexosamine residue on anticoagulant activity of fully O-sulfonated glycosaminoglycans. Glycoconj J 17, 393 399.
37. Volpi N, Mascellani G Bianchini P (1992) Low molecular weight heparins (5 kDa) and oligoheparins (2 kDa) produced by gel permeation enrichment or radical process: comparison of structures and physicochemical and biological properties. Anal Biochem 200, 100 107.
38. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533 537.
39. Pietrak BL, Crouthamel MC, Tugusheva K, Lineberger JE, Xu M, DiMuzio JM, Steele T, Espeseth AS, Stachel SJ, Coburn CA et al. (2005) Biochemical and cell-based assays for characterization of BACE-1 inhibitors. Anal Biochem 342, 144 151.
40. Chevallier N, Vizzavona J, Marambaud P, Baur CP, Spillantini M, Fulcrand P, Martinez J, Goedert M, Vincent JP Checler F (1997) Cathepsin D displays in vitro beta-secretase-like specificity. Brain Res 750, 11 19.
41. Ladror US, Snyder SW, Wang GT, Holzman TF Krafft GA (1994) Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J Biol Chem 269, 18422 18428.
42. Schechter I Ziv E (2008) Kinetic properties of cathepsin D and BACE 1 indicate the need to search for additional beta-secretase candidate(s). Biol Chem 389, 313 320.
43. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680 685.